BP000146-C147: Recombinant Human Interleukin-20 (IL-20) Protein
Source: E. coli-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP001385-C614: Recombinant Human Interleukin-20 receptor subunit alpha (IL20RA) Protein
Source: HEK 293-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000143-CYT-363: Recombinant Human IL-19
Source: E. coli-derived.
The activity is determined by it's ability to activate STAT following receptor-ligand interaction.
Purity > 99%, by SDS-PAGE and RP-HPLC.BP000143-CYT-411: Recombinant Mouse IL-19
Source: E. coli-derived.
The biological activity was determined by measuring the dose-dependent activation of STAT3 in human epidermal keratinocytes (HEK2a cells). Significant STAT3 activation is observed with >100 ug/ml corresponding to a Specific Activity of 10,000 IU/mg of recombinant mouse IL-19.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000146-CYT-347: Recombinant Human Interleukin-20 (IL-20) Protein
Source: E. coli-derived.
The Biological Activity was determined by measuring the dose dependent activation of STAT3 in human epidermal keratinocytes (HEKa cells).Significant STAT3 activation is observed with 100 ug/ml of recombinant human IL-20 corresponding to a Specific Activity of 10,000 IU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000146-CYT-379: Recombinant Mouse Interleukin-20 (IL-20) Protein
Source: E. coli-derived.
The biological activity was determined by measuring the dose dependent activation of STAT3 in human epidermal keratinocytes (HEK2a cells). Significant STAT3 activation is observed with >100 ug/ml corresponding to a specific activity of 1,000 U/mg of Interleukin-20 recombinant mouse.
Purity: > 95% by SDS-PAGE and RP-HPLC.